Chronic obstructive pulmonary disease

Global Chronic Obstructive Pulmonary Disease Treatment Devices Report to 2027 - Market Insights, Competitive Landscape and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, September 30, 2022
Health, Cardiology, Adult, Invacare, Competitive landscape, Patient, Particle size, Degenerative disease, Disease, Death, Microlife Corporation, COVID-19, Prevalence, Food, LAICA, Growth, Novartis, Inhaler, COVID, Genetics, Lupinus, PARI, Health care, Asthma, Mortality, LABA, CAGR, Hospital, Risk, Phlegm, FDA, Population, Air pollution, GlaxoSmithKline, Nebulizer, Disorder, AstraZeneca, Tobacco, MHRA, WHO, COPD, Medication, Cough, Incidence, Chronic obstructive pulmonary disease, World Health Organization, Dust, Medtronic, Metered-dose inhaler, Regulation of tobacco by the U.S. Food and Drug Administration, LAMA, Smoking, Awareness, Noble gas, Pharmaceutical industry, Dentistry, Geography

The "Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape and Market Forecast-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape and Market Forecast-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global chronic obstructive pulmonary disease (COPD) treatment devices market is estimated to grow at a CAGR of 6.37% during the forecast period from 2022 to 2027.
  • Chronic Obstructive Pulmonary Disease Treatment Devices Market Dynamics:
    The chronic obstructive pulmonary disease treatment devices market is witnessing a growth in product demand owing to various reasons such as the growing prevalence of COPD due to long-term exposure to air pollution, secondhand smoke and dust, fumes and chemicals.
  • Furthermore, rise in consumption of tobacco among youth population is anticipated to bolster the market for chronic obstructive pulmonary disease treatment devices during the forecast period.

The Worldwide Disposable Masks Industry is Expected to Reach $31.3 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 30, 2022
Medical Supplies, Health, Online, Ali Baba, Adoption, N95 respirator, Safety, NHS, Center, COVID-19, Hospital, Eyeish, Personal protective equipment, Prevalence, Disease, Virus, Internet, Pollen, World, World Health Organization, Tuberculosis, Dust, Mask, Air pollution, Pharmacy, N95, HAI, Market share, Growth, Patient, Clifton Springs Hospital & Clinic, Degenerative disease, SARS, Hospital-acquired infection, CDC, Bacteria, National Health Service, Korea Disease Control and Prevention Agency, WHO, Death, COPD, Awareness, Amazon, Subclinical infection, Asthma, Occupational Safety and Health Act 1994, PPE, Shop, Infection, Chronic obstructive pulmonary disease, CAGR, Animal, Application

The COVID-19 pandemic has resulted in a sharp increase in demand for disposable masks as individuals strive to protect themselves from the disease.

Key Points: 
  • The COVID-19 pandemic has resulted in a sharp increase in demand for disposable masks as individuals strive to protect themselves from the disease.
  • Disposable Masks are devices that are designed to protect the wearer from inhaling harmful airborne particles, bacteria, and viruses.
  • The rise in the number of confirmed cases is expected to drive the demand for face masks in the region.
  • For the purpose of this report, the author have segmented the global Disposable Masks market according to Product Type, Distribution Channel, Application, and Region:

Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

Retrieved on: 
Thursday, September 29, 2022
Medical Supplies, Medical Devices, Health, Manufacturing, General Health, Other Manufacturing, Health, Invacare, NYSE Listed Company Manual, Multiple sclerosis, Time, Rest, COVID-19, NYSE, ERP, Corporation, Intention, Compliance, IVC, Private Securities Litigation Reform Act, Calendar, Stroke, Forward-looking statement, U.S. Securities and Exchange Commission, Government, Investment, Risk, Transport, Birth, Spina bifida, Muscular dystrophy, The Rehabilitation Center at Hollywood Hills, ALS, Security (finance), New, COPD, Indian stock exchange, Annual report, Failure, Chronic obstructive pulmonary disease, Cerebral palsy, Health insurance, Risk management

The notice does not result in the immediate delisting of the companys Common Shares from the NYSE.

Key Points: 
  • The notice does not result in the immediate delisting of the companys Common Shares from the NYSE.
  • The company plans to notify the NYSE by October 7, 2022 that the company intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard.
  • The companys Common Shares will continue to be listed and trade on the NYSE during this period, subject to the companys compliance with other NYSE continued listing standards.
  • Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings.

Study Uncovers How Medical Device Bias Could Lead to 5-Hour Delays in COVID-19 Treatment for Black Patients

Retrieved on: 
Thursday, September 29, 2022
MPH, American Journal of Epidemiology, Algorithm, Human, COVID-19, Pulse, American Journal, Industry, 2009 Davis Cup, Knowledge, Palliative care, Review, Bias, Health equity, EGFR, California Medical Association, COVID, Respiratory disease, Patient, Sutter Health, Racism, CEO, Technology, Â, CDC, Solution, JAMA, Diagnosis, Death, FAHA, Research, COPD, GLOBE, Medicine, Skin, Decision-making, Awareness, Root, University, Maternal health, University of California Television, Color, Chronic obstructive pulmonary disease, EHR, Pharmaceutical industry, Medical device, Medical imaging, Physician, Black

The research revealed that pulse oximeter errors could have led Black patients to face a 4.5-hour delay in COVID-19 treatment.

Key Points: 
  • The research revealed that pulse oximeter errors could have led Black patients to face a 4.5-hour delay in COVID-19 treatment.
  • The findings underscore the fact that bias is not only human it can be engrained in the devices and tools clinicians rely on, too.
  • Examining How Bias Impacts Algorithms: Its not just humans or devices bias is also automated within medicine.
  • Ultimately, our goal is to eliminate health inequities and drive better health outcomes for patients in our network and nationwide.

Asia Pacific Air Treatment Market Report 2022-2028: Burgeoning Incidents of Chronic Health Issues due to Air Pollution Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 29, 2022
Other Health, General Health, Other Energy, Environmental Policy, Environmental Issues, Environmental Health, Alternative Energy, Energy, Environment, Construction & Property, Building Systems, Health, Health, COVID-19, Stainless steel, Air pollution, Life, Mining, Disease, Food, Degenerative disease, COPD, Mortality, Particulates, Atmosphere, APAC, Chronic obstructive pulmonary disease, CAGR, Speciality chemicals

The "Asia Pacific Air Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type and Application" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Air Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type and Application" report has been added to ResearchAndMarkets.com's offering.
  • As a result, the necessity for air treatment has been a key focus of governments worldwide, contributing to the air treatment market expansion.
  • There is substantial epidemiological evidence that air pollution is harmful to human health and is linked to respiratory disorders such as chronic obstructive pulmonary disease (COPD).
  • Further, based on country, the Asia Pacific air treatment market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC.

5 Steps for Women to Reduce Their Risk of COPD

Retrieved on: 
Thursday, September 29, 2022
People, Disability, Vaccine-preventable diseases, Smoke, COVID-19, Woman, Risk, National Heart Valve Disease Awareness Day, Herbal cigarette, Smoker, Life, Air pollution, News, Microsoft family features, Learning, Streptococcus, Lung, Exercise, National Heart, Lung, and Blood Institute, Wheeze, Degenerative disease, Sleep, Chronic obstructive pulmonary disease, COPD, Smoking, Man, Disease, Death, Tobacco, Pharmaceutical industry

Chronic obstructive pulmonary disease (COPD), a leading cause of disability and death in the United States, takes an especially heavy toll on women.

Key Points: 
  • Chronic obstructive pulmonary disease (COPD), a leading cause of disability and death in the United States, takes an especially heavy toll on women.
  • Women tend to develop COPD earlier in life than men and are more likely to have severe symptoms and be hospitalized with the disease.
  • According to the National Heart, Lung, and Blood Institute, there are steps you can take to reduce your risk for COPD.
  • Women with COPD tend to be diagnosed later than men when the disease is more severe and treatments are less effective.

NOTA Laboratories Signs Joint Development Agreement With NGK Sparkplugs

Retrieved on: 
Wednesday, September 28, 2022
Health, Engineering, NGK, Joint, ANN, Publication, Company, SIRS, NOTA, Urinary tract infection, CPB, Infection, Patient, Attention, Laboratory, CEO, Blood, Quality of life, Solution, Cardiopulmonary bypass, COPD, NO, PPHN, Chronic obstructive pulmonary disease, Pulmonary hypertension, Pharmaceutical industry

ANN ARBOR, Mich., Sept. 28, 2022 /PRNewswire/ -- NOTA Laboratories, a development stage company focused on proprietary nitric oxide (NO) delivery systems to treat a wide variety of acute and chronic respiratory and inflammatory illnesses, has just signed a Joint Development Agreement with NGK Spark Plugs of Nagoya, Japan.

Key Points: 
  • ANN ARBOR, Mich., Sept. 28, 2022 /PRNewswire/ -- NOTA Laboratories, a development stage company focused on proprietary nitric oxide (NO) delivery systems to treat a wide variety of acute and chronic respiratory and inflammatory illnesses, has just signed a Joint Development Agreement with NGK Spark Plugs of Nagoya, Japan.
  • NGK also own CAIRE Inc., a major supplier of oxygen concentrators for home, clinic, and hospital use and where NOTA's NO systems will have a substantial synergistic impact.
  • NOTA has two patented platform technologies that inexpensively generate NO "on-demand."
  • The medical products division is a key diversification strategy for the company through both internal and collaborative development that can have an impact on health and wellness.

UMass Chan Medical School and Wellinks Launch Study of Novel COPD Program

Retrieved on: 
Wednesday, September 28, 2022
Hospital, Health, Journal, Twitter, Risk, FDA, University of Massachusetts, Research, Conditional sentence, Medicine, University of Massachusetts Medical School, LinkedIn, News, NEW, U.S. News & World Report, Journal of Medical Internet Research, Patient, Medical school, Quality of life, Vaccine, Home, Benslie, List of Medknow Publications academic journals, Rehabilitation, University, Biomedical sciences, Education, HAVEN, Death, Chronic obstructive pulmonary disease, Self-management, Medical device, MD, Nout Wellink, Program, COPD

WORCESTER, Mass. and NEW HAVEN, Conn., Sept. 28, 2022 /PRNewswire/ -- UMass Chan Medical School and Wellinks, a digital healthcare company offering the first-ever integrated, virtual Chronic Obstructive Pulmonary Disease (COPD) management solution, today announced the launch of a new program, Healthy at Home, aimed at examining virtual care's ability to prevent acute care needs among people with COPD. This study is led by UMass Chan's Program in Digital Medicine and features Wellinks as a core element of an innovative approach towards chronic care management for COPD. Over the course of six months, researchers will evaluate the program's feasibility and impact on patient-reported outcomes, health care utilization, and total medical expenditure. Full results from the study are expected in mid-2023.

Key Points: 
  • This study is led by UMass Chan's Program in Digital Medicine and features Wellinks as a core element of an innovative approach towards chronic care management for COPD.
  • "Through our Healthy at Home collaboration with UMass Chan Medical School, we're helping more people living with COPD get the care they need to stay healthy and in control of their condition," said Dr. Abi Sundaramoorthy, Chief Medical Officer at Wellinks.
  • UMass Chan attracts more than $300 million annually in research funding, placing it among the top 50 medical schools in the nation.
  • In 2021, the Medical School received a $175 million donation from The Morningside Foundation and was renamed UMass Chan Medical School.

Global Air Purifier Market Report 2022: Rising Demand for Air Purifiers Due to Prevalence of Covid-19 Fueling Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 28, 2022
Other Manufacturing, Manufacturing, Adoption, Construction, Health, Smoke, Allergen, Incidence, Sharp, Application, Air pollution, Growth, Market share, Industry, USD, Degenerative disease, Urbanization, Air purifier, Restaurant, COPD, Water, Awareness, Particulates, Asthma, Chronic obstructive pulmonary disease, CAGR, Bottled water, Heating, ventilation, and air conditioning

The Air Purifier market is projected to reach USD 25.6 billion by 2030, according to a new report.

Key Points: 
  • The Air Purifier market is projected to reach USD 25.6 billion by 2030, according to a new report.
  • Air purifiers are devices which help in the removal of particulate matter, allergens, smoke, and other airborne contaminants from the indoor air.
  • The growing awareness about the harmful effects of air pollution is one of the major factors driving the growth of the air purifier market.
  • The rising need for air pollution control equipment and the implementation of stringent environmental regulations are expected to contribute to the growth of air purifier market.

United States Breath Analyzers Market Trends, Analysis & Forecasts Report 2022-2030 - Growing Demand from Law Enforcement Agencies and Other Institutions Such as Schools, Sports, and Offices - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 28, 2022
Technology, Hardware, Semiconductor, Carbon, Transport, Sexual abuse, COVID-19, Chronic obstructive pulmonary disease, Prevalence, Accident, Canada, Ministry of Transportation of Ontario, Tuberculosis, Growth, U.S. Department of Defense Strategy for Operating in Cyberspace, IR, Patient, Cancer, Molecule, Sport, Diagnosis, Drinking, School, Ontario Ministry of Citizenship and Immigration, COPD, Smoking, Infection, CAGR, Pharmaceutical industry, Animal

Breath Analyzers Market Size, Share & Trends Analysis Report 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Breath Analyzers Market Size, Share & Trends Analysis Report 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • Growing demand for breath analyzers from law enforcement agencies and other institutions such as schools, sports, and offices to minimize alcohol abuse is a major market driver.
  • Breath analyzers offer a quick primary diagnosis based on exhaled air contents.
  • Sometimes breath analyzers provide inaccurate results, failing to differentiate alcohol from any other chemical compound that holds a methyl group structure.